Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review.
about
Role of "Western diet" in inflammatory autoimmune diseasesThe human disease network in terms of dysfunctional regulatory mechanismsObesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes.Soy Isoflavones Regulate Lipid Metabolism through an AKT/mTORC1 Pathway in Diet-Induced Obesity (DIO) Male Rats.Soyasaponins can blunt inflammation by inhibiting the reactive oxygen species-mediated activation of PI3K/Akt/NF-kB pathwayA small amount of dietary carbohydrate can promote the HFD-induced insulin resistance to a maximal levelProlonged exposure to insulin induces mitochondrion-derived oxidative stress through increasing mitochondrial cholesterol content in hepatocytes.Insulin and insulin signaling play a critical role in fat induction of insulin resistance in mouse.Constitutive role for IRE1α-XBP1 signaling pathway in the insulin-mediated hepatic lipogenic programFine-tuned regulation of the PGC-1α gene transcription by different intracellular signaling pathways.Hepatic autophagy is suppressed in the presence of insulin resistance and hyperinsulinemia: inhibition of FoxO1-dependent expression of key autophagy genes by insulin.Biological and other health related correlates of long-term life dissatisfaction burdenSerum leptin and adiponectin levels in Korean patients with psoriasis.Impact of metabolic status on the incidence of psoriasis: a Korean nationwide cohort studyNo association between psoriasis and diabetes in the U.S. population.Correlation between psoriasis' severity and waist-to-height ratio.Obesity, waist circumference, weight change and the risk of psoriasis in US women.Obesity and risk of incident psoriatic arthritis in US womenProteolytic activation of prochemerin by kallikrein 7 breaks an ionic linkage and results in C-terminal rearrangement.Being overweight or obese and risk of developing rheumatoid arthritis among women: a prospective cohort study.IL-17 regulates adipogenesis, glucose homeostasis, and obesity.Metabolic syndrome and its components in patients with psoriasis.Biologics in the management of psoriasis.Leptin levels in patients with psoriasis: a meta-analysis.Clinico-biochemical correlation between psoriasis and insulin resistanceEvaluation of cardiovascular disease risk factors in patients with mycosis fungoides.Increased prevalence of the metabolic syndrome in patients with psoriatic arthritisAdipose tissue dendritic cells enhances inflammation by prompting the generation of Th17 cells.The association of psoriasis and elevated blood lipids in overweight and obese children.Psoriasis and increased prevalence of hypertension and diabetes mellitus.Cardiovascular comorbiditiy in psoriasisEvaluating practice patterns for managing moderate to severe plaque psoriasis: role of the family physician.Randomized placebo control study of insulin sensitizers (Metformin and Pioglitazone) in psoriasis patients with metabolic syndrome (Topical Treatment Cohort).Prevalence of metabolic syndrome in South Indian patients with psoriasis vulgaris and the relation between disease severity and metabolic syndrome: a hospital-based case-control study.Prevalence of Metabolic Syndrome in Psoriasis Patients and its Relation to Disease Duration: A Hospital Based Case-Control StudyJuvenile Psoriatic Arthritis (JPsA): juvenile arthritis with psoriasis?Assessment of adiposity in psoriatic patients by dual energy X-ray absorptiometry compared to conventional methodsNational Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening.Psoriasis and metabolic disease: epidemiology and pathophysiologyCardiometabolic risk in psoriasis: differential effects of biologic agents.
P2860
Q26996114-B19EC545-0F31-468B-BB7C-232D4FDE506DQ28550156-8E8AF912-7F20-4365-AA30-2C2E20BB2CADQ30239737-F82474F8-0814-479A-BD16-2438ABADE051Q30387784-58A6DAC2-D11D-4498-AC56-C295611A901DQ30410617-5CA32455-65FF-4704-B46F-C79C9A8E0C0FQ30411774-B61ED3D5-A3CE-4FC1-8A08-545B0E9C5977Q30419525-5A3AE179-A442-47A6-94F6-590581731E1CQ30425682-32820583-3C1A-48B2-938D-86131B8182B4Q30426645-B2038408-F123-4433-9A1B-B19AA1723FECQ30427993-9316C2E7-493F-4E74-B86F-4AB2D128D85DQ30434199-438B4799-5BAF-4ACE-B49D-582924327956Q31125660-DDD115DD-1EA4-41D6-B16F-B417A6514232Q33627496-1A48101B-7A18-4412-B054-B1495F23D217Q33694555-38A7D9A4-EC15-4D7E-A833-0A8F11F49205Q33796202-7BA6D3D0-0EE9-4007-97B7-10E554830A5FQ34140605-4E983AF0-D916-4ED5-A66F-555717D10307Q34266151-1242FA9B-38E4-4735-8350-5F7412BA3F84Q34283211-FFA77935-4C46-4E6A-BF9E-C263AA334A39Q34333142-39BA8BB9-5890-429B-9A90-3B653F993EBBQ34392481-1F101075-1B2C-462F-8AD8-0EFA72DC6544Q34401701-FFC06F09-8CBC-4691-8835-A122B6C4F074Q34409690-6F7787BB-86E4-4F00-AE44-647DB2E9E198Q34620257-92366DC1-DECD-4AB7-A3F6-5B637BD02BC8Q34777416-8743104C-9560-4538-B8F8-70C64B7CAD34Q35028089-600A959D-BD3A-4346-995D-0373B33F2D4AQ35070294-8FF283BC-1C58-4492-B02D-002CE12D1B96Q35086458-B0059A5D-4C89-4154-8A2D-891B972B3951Q35124175-F2F2A8AB-F369-4E3D-ACF3-5CB082A18DB2Q35199755-08883C19-EF95-435A-8B0F-BAF543C4E9DAQ35564637-2864B195-6623-4F87-A150-797E8B3F637BQ35564655-C373465B-0D26-41E9-86FD-933720F131F9Q36091617-F8051AE9-F6C0-44AA-BCDA-032D5AD2864EQ36105361-967365DB-16D6-4B25-8489-E714E8F92139Q36352320-EB7C9043-B441-46A4-ABDA-64BEDEDF3F3DQ36708804-059DDFD2-1874-45D7-A025-1551EA153269Q36755481-00FD3179-7250-4C5A-8E70-B8C79886E129Q36885064-F90403F5-3FE2-4CB7-9E8A-EE40507FE8B0Q37027264-6E9EA9B3-1C24-4A29-B2A7-CDDED7B48F8BQ37102789-2B9E8D19-CA00-40E9-BC1F-3F4D73824CACQ37145684-5482C5B5-F874-4AFE-86E8-072176547F77
P2860
Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Obesity in psoriasis: the meta ...... plinary conference and review.
@en
type
label
Obesity in psoriasis: the meta ...... plinary conference and review.
@en
prefLabel
Obesity in psoriasis: the meta ...... plinary conference and review.
@en
P2093
P2860
P1476
Obesity in psoriasis: the meta ...... plinary conference and review.
@en
P2093
B E Strober
International Psoriasis Council
P2860
P304
P356
10.1111/J.1365-2133.2007.08068.X
P407
P577
2007-07-11T00:00:00Z